December 21, 2020

Walgreens and Labcorp make Pixel by Labcorp™ at-home COVID-19 collection kit available through Walgreens Find Care®

DEERFIELD, Ill. & BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 21, 2020-- Labcorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, and Walgreens today announced that the Pixel by Labcorp™ At-Home COVID-19 Collection Kit is now available from Labcorp through Walgreens Find Care®, a digital health platform available on the Walgreens app and Walgreens.com. Walgreens currently offers COVID-19 testing in more than 1,100 drive-thru locations across the country.
<span>Labcorp and Rush University System for Health enter into a partnership focused on laboratory, clinical trial and data service</span>
December 18, 2020

Labcorp and Rush University System for Health enter into a partnership focused on laboratory, clinical trial and data service

Labcorp now serves as the primary lab for the RUSH network as it embarks on a comprehensive clinical trials relationship Labcorp (NYSE: LH) has entered into a comprehensive partnership with Rush University System for Health (RUSH) to serve as the primary lab for Chicago-based hospitals and physicians in the RUSH network. RUSH will also operate as a site partner for clinical trials through Labcorp’s drug development business, Covance. Together, Labcorp’s diagnostics and drug development expertise, along with RUSH’s deep roots in integrated, academic medicine, will enable scientific innovations and new care options for the communities RUSH serves.
<span>Labcorp evolves its brand to showcase its role as a trusted source in healthcare</span>
December 16, 2020

Labcorp evolves its brand to showcase its role as a trusted source in healthcare

BURLINGTON, N.C., Dec. 16, 2020 — Labcorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, is evolving its brand identity to highlight the pivotal role the company plays in healthcare and showcase the power of the company’s diagnostic and drug development offerings. Labcorp started as a diagnostics company over 50 years ago. Today, it employs over 70,000 people worldwide and impacts more than 160 million lives annually through diagnostic insights and the development of innovative, life-changing treatments. 

Labcorp Evolves Its Brand to Showcase Its Role as a Trusted Source in Healthcare

<span>Roche receives FDA Emergency Use Authorization for new semi-quantitative test to measure the level of SARS-CoV-2 antibodies</span>
December 1, 2020

Roche receives FDA Emergency Use Authorization for new semi-quantitative test to measure the level of SARS-CoV-2 antibodies

INDIANAPOLIS, Dec. 1, 2020 /PRNewswire/ -- Roche (SIX: RO, ROG;OTCQX: RHHBY) today announced that its Elecsys® Anti-SARS-CoV-2 S antibody test has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). The semi-quantitative serology (blood) test can be used to measure the level of antibodies in people who have been exposed to the SARS-CoV-2 virus.